Antiviral treatments over cell-to-cell infection: Is it just a matter of dose?

AIDS

Volumn 27, Issue 15, 2013, Pages 2481-2483

  Moris, Arnaud ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiretroviral therapy; Cell cell; Cell to cell spread; HIV; Multiplicity of infection

Indexed keywords

ANTIVIRUS AGENT; RALTEGRAVIR;

ANTIVIRAL THERAPY; CD4+ T LYMPHOCYTE; CELL TRANSFER; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; INTERNALIZATION; MACROPHAGE; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL; VIRAL CLEARANCE; VIRION; VIRUS ENVELOPE; VIRUS PARTICLE; VIRUS REPLICATION;

ANTI-RETROVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; HIV-1; HUMANS; MACROPHAGES;

EID: 84884470406     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000432447.45486.03     Document Type: Note

References (19)

1. Duncan CJA, Russell RA, Sattentau QJ. High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy. AIDS 2013; 27:2201-2206.
2. Martin N, Sattentau Q. Cell-to-cell HIV-1 spread and its implications for immune evasion. Curr Opin HIV AIDS 2009; 4:143-149.
3. Mc D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, Hope TJ. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003; 300:1295-1297.
4. Felts Rl, Narayan K, Estes JD, Shi D, Trubey CM, Fu J, et al. 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A 2010; 107:13336-13341.
5. Rodriguez-Plata MT, Puigdomenech I, Izquierdo-Useros N, Puertas MC, Carrillo J, Erkizia I, et al. The infectious synapse formed between mature dendritic cells and CD4+ T cells is independent of the presence of the HIV-1 envelope glycoprotein. Retrovirology 2013; 10:42.
6. Nobile C, Petit C, Moris A, Skrabal K, Abastado JP, Mammano F, et al. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J Virol 2005; 79: 5386-5399.
7. Monel B, Beaumont E, Vendrame D, Schwartz O, Brand D, Mammano F. HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores. J Virol 2012; 86:3924-3933.
8. Bennett AE, Narayan K, Shi D, Hartnell LM, Gousset K, He H, et al. Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathogens 2009; 5:e1000591.
9. Jouve M, Sol-Foulon N, Watson S, Schwartz O, Benaroch P. HIV-1 buds and accumulates in ''nonacidic'' endosomes of macrophages. Cell Host Microbe 2007; 2:85-95.
10. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009; 15:893-900.
11. Zalar A, Figueroa MI, Ruibal-Ares B, Bare P, Cahn P, de Bracco MM, et al. Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART. Antivir Res 2010; 87:269-271.
12. Sigal A, Baltimore D. As good as it gets? The problem of HIV persistence despite antiretroviral drugs. Cell Host Microbe 2012; 12:132-138.
13. Sigal A, Kim JT, Balazs AB, Dekel E, Mayo A, Milo R, et al. Cellto-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature 2011; 477:95-98.
14. Permanyer M, Ballana E, Ruiz A, Badia R, Riveira-Munoz E, Gonzalo E, et al. Antiretroviral agents effectively block HIV replication after cell-to-cell transfer. J Virol 2012; 86:8773-8780doi: 10.1128/JVI.01044-12.
15. Martin N, Welsch S, Jolly C, Briggs JA, Vaux D, Sattentau QJ. Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. J Virol 2010; 84:3516-3527.
16. Kang Y, Wu Z, Lau TC, Lu X, Liu L, Cheung AK, et al. CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant. J Biol Chem 2012; 287:16499-16509.
17. Gupta P, Lackman-Smith C, Snyder B, Ratner D, Rohan LC, Patton D, et al. Antiviral activity of retrocyclin RC-101, a candidate microbicide against cell-associated HIV-1. AIDS Res Hum Retroviruses 2013; 29:391-396.
18. Su B, Xu K, Lederle A, Peressin M, Biedma ME, Laumond G, et al. Neutralizing antibodies inhibit HIV-1 transfer from primary dendritic cells to autologous CD4 T lymphocytes. Blood 2012; 120:3708-3717.
19. Cory TJ, Schacker TW, Stevenson M, Fletcher CV. Overcoming pharmacologic sanctuaries. Curr Opin HIV AIDS 2013; 8:190-195.